Studio dedicato a quanti prendono il decaffeinato perché la caffeina fa male al cuore.
J Epidemiol Community Health. 2009 Dec 8. [Epub ahead of print]
Coffee, green tea, black tea and oolong tea consumption and risk of
mortality from cardiovascular disease in Japanese men and women.
Mineharu Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, Yamamoto A,
Kikuchi S, Inaba Y, Toyoshima H, Kondo T, Tamakoshi A.
BACKGROUND: The effects of coffee and green, black and oolong teas and
caffeine intake on cardiovascular disease (CVD) mortality have not
been well defined in Asian countries. METHODS: To examine the
relationship between consumption of these beverages and risk of
mortality from CVD, we prospectively followed 76,979 individuals aged
40-79 y free of stroke, coronary heart disease (CHD), and cancer at
entry. Daily consumption of beverages was assessed by questionnaires.
RESULTS: We documented 1362 deaths from strokes and 650 deaths from
CHD after 1,010,787 person-years of follow-up . Compared with non-
drinkers of coffee, the multivariable hazard ratios (HRs) and 95%
confidence interval for those drinking 1-6 cups/wk, 1-2 cups/d and a
per thousandPsi3 cups/d were 0.78 (0.50-1.20), 0.67 (0.47-0.96) and
0.45 (0.17-0.87) for strokes among men (p=0.009 for trend). Compared
with non-drinkers of green tea, the multivariable HRs for those
drinking 1-6 cups/wk, 1-2 cups/d, 3-5 cups/d and a per thousandPsi6
cups/d were 0.34 (0.06-1.75), 0.28 (0.07-1.11), 0.39 (0.18-0.85), and
0.42 (0.17-0.88) for CHD among women (p=0.038 for trend). As for
oolong tea, the multivariable HRs of those drinking 1-6 cups/wk and a
per thousandPsi1 cups/d were 1.00 (0.65-1.55) and 0.39 (0.17-0.88) for
total CVD among men (p=0.049 for trend). Risk reduction for total CVD
across categories of caffeine intake was most prominently observed in
the second highest quintile with a 38% lower risk among men and 22%
among women. CONCLUSIONS: Consumption of coffee, green tea and oolong
tea and total caffeine intake was associated with a reduced risk of
mortality from CVD.
PMID: 19996359 [PubMed - as supplied by publisher]